GlassScriptPhysician profile
Padmaja Sanaka
NPI 1255646055
$1,170.45
in general payments reported to CMS, 2019-2025
23 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $26.66 · 2021: $227 · 2022: $148 · 2023: $85.40 · 2024: $375 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $125.00 | 2025 | Jardiance |
| Hologic Sales and Service, LLC | $116.12 | 2020-2022 | |
| Abbvie INC. | $106.25 | 2019-2024 | |
| Coopersurgical, INC. | $88.17 | 2022-2024 | Paragard T 380a, Paragard T 380a |
| Exact Sciences Corporation | $83.69 | 2023-2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $78.49 | 2019 | |
| Merck Sharp & Dohme LLC | $74.75 | 2021-2024 | Gardasil 9, Gardasil |
| Pfizer INC. | $69.93 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $61.65 | 2024 | |
| Astellas Pharma US INC | $60.80 | 2024 | Veozah |
| Exeltis, USA INC. | $48.75 | 2022-2025 | Slynd |
| Agile Therapeutics, INC. | $45.64 | 2021 | |
| Intuitive Surgical, INC. | $41.16 | 2019-2020 | |
| Meditrina | $26.97 | 2021 | |
| Sumitomo Pharma America, INC. | $22.50 | 2024 | Gemtesa |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $18.87 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.74 | 2024 | Xifaxan |
| Novo Nordisk INC | $18.04 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.71 | 2024 | |
| Shield Therapeutics INC | $14.35 | 2022 | |
| Organon LLC | $12.12 | 2025 | Nexplanon |
| Minerva Surgical, INC | $11.92 | 2022 | |
| Therapeuticsmd, INC. | $11.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Padmaja Sanaka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.